Identification
- Composition (DCI)
- amlodipinevalsartanhydrochlorothiazide
- Manufacturer
- NOVARTIS PHARMA MAROC
- ATC code
- C09DX01
- Presentation
- Boite de 28
- Schedule / Reimb.
- A
- Hospital price
- 190.70 MAD
Indications
Traitement de l'hypertension artérielle essentielle. Exforge HCT est indiqué pour les patients dont la tension artérielle est insuffisamment contrôlée par une bithérapie. Exforge HCT est indiqué en traitement de remplacement chez les patients recevant déjà du valsartan, de l'amlodipine et de l'hydrochlorothiazide sous forme de comprimés séparés aux mêmes dosages. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About EXFORGE HCT 5 MG / 160 MG / 25 MG
EXFORGE HCT 5 MG / 160 MG / 25 MG is marketed in Morocco by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of EXFORGE HCT 5 MG / 160 MG / 25 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about EXFORGE HCT 5 MG / 160 MG / 25 MG
Answers to common questions from Moroccan patients about this drug.